<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>03760271870708</udiDi>
    <basicUdiDi>B-03760271870708</basicUdiDi>
    <tradeName>VISCODERM Skinko E</tradeName>
    <deviceName>VISCODERM Skinko E</deviceName>
    <manufacturerName>REVITACARE SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000004021</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0301</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VE532</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T00:03:39.859Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760271870685</udiDi>
    <basicUdiDi>B-03760271870685</basicUdiDi>
    <tradeName>VISCODERM Skinko</tradeName>
    <deviceName>VISCODERM Skinko</deviceName>
    <manufacturerName>REVITACARE SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000004021</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0301</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>VS502</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T00:03:39.066Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760271870661</udiDi>
    <basicUdiDi>B-03760271870661</basicUdiDi>
    <tradeName>DERMASTIR 16 EBF</tradeName>
    <deviceName>DERMASTIR 16 EBF</deviceName>
    <manufacturerName>REVITACARE SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000004021</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0301</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DE1/5</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T00:03:38.278Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760271870654</udiDi>
    <basicUdiDi>B-03760271870654</basicUdiDi>
    <tradeName>DERMASTIR 32 EBF</tradeName>
    <deviceName>DERMASTIR 32 EBF</deviceName>
    <manufacturerName>REVITACARE SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000004021</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0301</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DE2/5</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T00:03:34.251Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760271870647</udiDi>
    <basicUdiDi>B-03760271870647</basicUdiDi>
    <tradeName>DERMASTIR H13</tradeName>
    <deviceName>DERMASTIR H13</deviceName>
    <manufacturerName>REVITACARE SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000004021</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0301</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DE3/5</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T00:03:33.455Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760271870418</udiDi>
    <basicUdiDi>B-03760271870418</basicUdiDi>
    <tradeName>REVITAFILL Essential 4</tradeName>
    <deviceName>REVITAFILL Essential 4</deviceName>
    <manufacturerName>REVITACARE SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000004021</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FE401</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T00:03:32.683Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760271870401</udiDi>
    <basicUdiDi>B-03760271870401</basicUdiDi>
    <tradeName>REVITAFILL Essential 3</tradeName>
    <deviceName>REVITAFILL Essential 3</deviceName>
    <manufacturerName>REVITACARE SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000004021</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FE301</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T00:03:31.857Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760271870333</udiDi>
    <basicUdiDi>B-03760271870333</basicUdiDi>
    <tradeName>CYTOCARE S Line</tradeName>
    <deviceName>CYTOCARE S Line</deviceName>
    <manufacturerName>REVITACARE SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000004021</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CTSL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T00:03:27.861Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760271870159</udiDi>
    <basicUdiDi>B-03760271870159</basicUdiDi>
    <tradeName>CYTOCARE 502</tradeName>
    <deviceName>CYTOCARE 502</deviceName>
    <manufacturerName>REVITACARE SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000004021</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0301</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CZ502/5</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T00:03:27.055Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760271870395</udiDi>
    <basicUdiDi>B-03760271870395</basicUdiDi>
    <tradeName>REVITAFILL Essential 2</tradeName>
    <deviceName>REVITAFILL Essential 2</deviceName>
    <manufacturerName>REVITACARE SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000004021</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FE201</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T00:03:26.251Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760271870388</udiDi>
    <basicUdiDi>B-03760271870388</basicUdiDi>
    <tradeName>REVITAFILL Essential 1</tradeName>
    <deviceName>REVITAFILL Essential 1</deviceName>
    <manufacturerName>REVITACARE SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000004021</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FE101</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T00:03:25.558Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760271870142</udiDi>
    <basicUdiDi>B-03760271870142</basicUdiDi>
    <tradeName>CYTOCARE 516</tradeName>
    <deviceName>CYTOCARE 516</deviceName>
    <manufacturerName>REVITACARE SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000004021</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0301</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CY516/5</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T00:03:08.608Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760271870135</udiDi>
    <basicUdiDi>B-03760271870135</basicUdiDi>
    <tradeName>CYTOCARE 532</tradeName>
    <deviceName>CYTOCARE 532</deviceName>
    <manufacturerName>REVITACARE SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000004021</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0301</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CT532/5</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T00:03:07.813Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760271870036</udiDi>
    <basicUdiDi>B-03760271870036</basicUdiDi>
    <tradeName>HAIRCARE</tradeName>
    <deviceName>HAIRCARE</deviceName>
    <manufacturerName>REVITACARE SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000004021</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0301</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HR002</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T00:03:07.014Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760271870029</udiDi>
    <basicUdiDi>B-03760271870029</basicUdiDi>
    <tradeName>CYTOCARE 502</tradeName>
    <deviceName>CYTOCARE 502</deviceName>
    <manufacturerName>REVITACARE SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000004021</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0301</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CZ502</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T00:03:06.212Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760271870012</udiDi>
    <basicUdiDi>B-03760271870012</basicUdiDi>
    <tradeName>CYTOCARE 516</tradeName>
    <deviceName>CYTOCARE 516</deviceName>
    <manufacturerName>REVITACARE SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000004021</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0301</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CY516</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T00:03:02.211Z</lastUpdated>
  </row>
  <row>
    <udiDi>03760271870005</udiDi>
    <basicUdiDi>B-03760271870005</basicUdiDi>
    <tradeName>CYTOCARE 532</tradeName>
    <deviceName>CYTOCARE 532</deviceName>
    <manufacturerName>REVITACARE SAS</manufacturerName>
    <manufacturerSrn>FR-MF-000004021</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0301</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CT532</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T00:03:01.420Z</lastUpdated>
  </row>
</eudamedExport>